Does poly ( ADP-ribose ) polymerase inhibition attenuate biventricular reperfusion injury after orthotopic heart transplantation?
PARP inhibition reduces myocardial and endothelial reperfusion injury after orthotopic heart transplantation.
In CI recipients, IM cannot be reduced by means of differences in f0 between the competing talkers, but only by level differences. This might be explained by the restricted spectral resolution and the insufficient transmission of f0 in CIs. Adverse effects in NL can predominantly be attributed to IM, while additional masking effects take place in CI recipients.